Modified Maximal Thymectomy for Myasthenia Gravis: Effect of Maximal Resection on Late Neurologic Outcome and Predictors of Disease Remission

Annals of Thoracic Surgery

Volumn 88, Issue 5, 2009, Pages 1638-1645

  Prokakis, Christos ^a   Koletsis, Efstratios ^a   Salakou, Stavroula ^a   Apostolakis, Efstratios ^a   Baltayiannis, Nikolaos ^b   Chatzimichalis, Antonios ^b   Papapetropoulos, Theodoros ^a   Dougenis, Dimitrios ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b METAXA CANCER HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE; PYRIDOSTIGMINE; STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; CHOLINERGIC CRISIS; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MYASTHENIA; MYASTHENIA GRAVIS; MYASTHENIC CRISIS; NEUROLOGICAL COMPLICATION; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RECURRENT LARYNGEAL NERVE PALSY; REMISSION; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL APPROACH; SURGICAL INFECTION; SURGICAL RISK; THYMECTOMY; THYMOMA; TREATMENT OUTCOME; TUMOR LOCALIZATION; WORLD HEALTH ORGANIZATION; METHODOLOGY; MIDDLE AGED; NEUROLOGIC EXAMINATION; PROGNOSIS; TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; NEUROLOGIC EXAMINATION; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; THYMECTOMY; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70449706342     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.07.036     Document Type: Article

References (35)

1. Gronseth G.S., and Barohn R.J. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55 (2000) 7-15
2. Jaretzki A., Steinglass K.M., and Sonett J.R. Thymectomy in the management of myasthenia gravis. Semin Neurol 24 (2004) 49-62
3. Jaretzki III A., Penn A.S., Younger D.S., et al. "Maximal" thymectomy for myasthenia gravis. Results. J Thorac Cardiovasc Surg 95 (1988) 47-57
4. Jaretzki III A., Barohn R.J., Ernstoff R.M., et al. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Myasthenia Gravis: recommendations for clinical research standards. Ann Thorac Surg 70 (2000) 327-334
5. Salakou S., Tsamandas A.C., Bonikos D.S., Papapetropoulos T., and Dougenis D. The potential role of bcl-2, bax and Ki67 expression in thymus of patients with myasthenia gravis and their correlation with clinicopathologic parameters. Eur J Cardiothorac Surg 20 (2001) 712-721
6. Jaretzki III A., and Wolff M. Maximal thymectomy for myasthenia gravis. Surgical anatomy and operative technique. J Thorac Cardiovasc Surg 96 (1988) 711-716
7. Bulkley G.B., Bass K.N., Stephenson G.R., et al. Extended cervicomediastinal thymectomy in the integrated management of myasthenia gravis. Ann Surg 226 (1997) 324-334
8. Bril V., Kojic J., Ilse W.K., and Cooper J.D. Long term clinical outcome after transcervical thymectomy for myasthenia gravis. Ann Thorac Surg 65 (1998) 1520-1522
9. Masaoka A., Yamakawa Y., Niwa H., et al. Extended thymectomy for myasthenia gravis patients: a 20-year review. Ann Thorac Surg 62 (1996) 853-859
10. Scott W., and Detterbeck F. Transsternal thymectomy for myasthenia gravis. Semin Thorac Cardiovasc Surg 11 (1999) 54-58
11. Jaretzki III A. Thymectomy for myasthenia gravis: analysis of controversies-patient management. Neurologist 9 (2003) 77-92
12. Essa M., El-Medany Y., Hajjar W., et al. Maximal thymectomy in children with myasthenia gravis. Eur J Cardiothorac Surg 24 (2003) 187-189
13. Kas J., Kiss D., Simon V., Svastics E., Major L., and Szobor A. Decade-long experience with surgical therapy of myasthenia gravis: early complications of 324 transsternal thymectomies. Ann Thorac Surg 72 (2001) 1691-1697
14. Zieliński M., Kuzdzał J., Szlubowski A., and Soja J. Transcervical-subxiphoid-thoracoscopic maximal thymectomy-operative technique and early results. Ann Thorac Surg 78 (2004) 404-409
15. Tomulescu V., Ion V., Kosa A., Sgarbura O., and Popescu I. Thoracoscopic thymectomy mid-term results. Ann Thorac Surg 82 (2006) 1003-1007
16. Calhoun R.F., Ritter J.H., Guthrie T.J., et al. Results of transcervical thymectomy for myasthenia gravis in 100 consecutive patients. Ann Surg 230 (1999) 555-559
17. Khicha S.G., Kaiser L.R., and Shrager J.B. Extended transcervical thymectomy in patients with myasthenia gravis. Ann N Y Acad Sci 1132 (2008) 336-343
18. Sekine Y., Kawaguchi N., Hamada C., et al. Does perioperative high-dose prednisolone have clinical benefits for generalized myasthenia gravis?. Eur J Cardiothorac Surg 29 (2006) 908-913
19. Watanabe A., Watanabe T., Obama T., et al. Prognostic factors for myasthenic crisis after transsternal thymectomy in patients with myasthenia gravis. J Thorac Cardiovasc Surg 127 (2004) 868-876
20. Ashour M. Prevalence of ectopic thymic tissue in myasthenia gravis and its clinical significance. J Thorac Cardiovasc Surg 109 (1995) 632-635
21. Papatestas A.E., Genkins G., Kornfeld P., et al. Effects of thymectomy in myasthenia gravis. Ann Surg 206 (1987) 79-88
22. Park I.K., Choi S.S., Lee J.G., Kim D.J., and Chung K.Y. Complete stable remission after extended transsternal thymectomy in myasthenia gravis. Eur J Cardiothorac Surg 30 (2006) 525-528
23. El-Medany Y., Hajjar W., Essa M., Al-Kattan K., Hariri Z., and Ashour M. Predictors of outcome for myasthenia gravis after thymectomy. Asian Cardiovasc Thorac Ann 11 (2003) 323-327
24. Hsu H.S., Huang C.S., Huang B.S., et al. Thymoma is associated with relapse of symptoms after transsternal thymectomy for myasthenia gravis. Interact Cardiovasc Thorac Surg 5 (2006) 42-46
25. Kim H.K., Park M.S., Choi Y.S., et al. Neurologic outcomes of thymectomy in myasthenia gravis: comparative analysis of the effect of thymoma. J Thorac Cardiovasc Surg 134 (2007) 601-607
26. Mantegazza R., Baggi F., Bernasconi P., et al. Video-assisted thoracoscopic extended thymectomy and extended transternal thymectomy (T-3b) in non-thymomatous myasthenia gravis patients: remission after 6 years of follow up. J Neurol Sci 212 (2003) 31-36
27. Augustin F., Schmid T., Sieb M., Lucciarini P., and Bodner J. Video-assisted thoracoscopic surgery versus robotic-assisted thoracoscopic surgery thymectomy. Ann Thorac Surg 85 (2008) S768-S771
28. Fleck T.M., Fleck M., Mueller M., et al. Extended videoscopic robotic thymectomy with the da Vinci telemanipulator for the treatment of myasthenia gravis: the Vienna experience. Interact Cardiovasc Thorac Surg (2009) [Epub ahead of print]
29. De Perrot M., Bril V., McRae K., and Keshavjee S. Impact of minimally invasive trans-cervical thymectomy on outcome in patients with myasthenia gravis. Eur J Cardiothorac Surg 24 (2003) 677-683
30. Deymeer F., Gungor-Tuncer O., Yilmaz V., et al. Clinical comparison of anti-MuSK vs anti-AChR positive and sieronegative myasthenia gravis. Neurology 68 (2007) 609-611
31. Ponseti J.M., Caritg N., Gamez J., López-Cano M., Vilallonga R., and Armengol M. A comparison of long term post-thymectomy outcome of anti-AChR positive, anti-AChR negative and anti-MuSK positive patients with non thymomatous myasthenia gravis. Expert Opin Biol Ther 9 (2009) 1-8
32. Salakou S., Kardamakis D., Tsamandas A.C., et al. Increased Bax/Blc-2 ratio upregulates caspase-3 and increases apoptosis in thymus of patients with myasthenia gravis. In Vivo 21 (2007) 123-132
33. Lopez-Cano M., Ponseti-Bosch J.M., Espin-Basany E., Sanchez-Garcia J.L., and Armengol-Carrasco M. Clinical and pathological predictors of outcome in thymoma-associated myasthenia gravis. Ann Thorac Surg 76 (2003) 1643-1649
34. Chen X.J., Qiao J., Xiao B.G., and Lu C.Z. The significance of titin antibodies in myasthenia gravis-correlation with thymoma and severity of myasthenia gravis. J Neurol 251 (2004) 1006-1011
35. Skeie G.O., Aarli J.A., and Gilhus N.E. Titin and ryanodine receptor antibodies in myasthenia gravis. Acta Neurol Scand Suppl 183 (2006) 19-23